Medtech Innovation '26 Helsinki Summit

Elevate your EIC-funded breakthrough on Europe’s definitive acceleration platform.

The MTI25 EIC Showcase Track is more than a pitching opportunity. Provided by inXso, it is a comprehensive Fundraising as a Service (FaaS) journey that begins with your investor pitch on 16 March and continues through a high-intensity strategic stress-test to help you close your funding round by 31 May 2026.

Securing institutional capital in 2026 requires Evidence Maturity. Investors no longer buy into technological novelty alone; they demand auditable regulatory trajectories and bulletproof “Path to Payment” logic.

What’s in it for you?

• Direct Investor Exposure: Pitch your venture on the dedicated EIC Showcase Track to international Series A/B investors and strategic healthcare partners.
• Collaborative Stress-Testing: We do not write your plan; we make it bulletproof. You lead the strategy using the inXso Funding Strategy Template, and our experts provide the technical “Red Teaming” to identify and resolve diligence red flags.
• Valuation Protection: Use the post-summit weeks to solidify your regulatory and clinical narrative—a strategy proven to support pre-money valuations up to 25% higher than peer ventures.
• Specialised Consultations: Gain expert guidance on IP/FTO, Nordic Testbeds, and complex EU mandates (HTAR/SoHO).

The FemTech Pioneer Award

MTI25 is committed to closing the historical funding gap in women’s health. We highly encourage FemTech innovators to apply.

• The Award: One top-performing FemTech venture will receive the MTI25 Women’s Health Pioneer Award.
• The Prize: This includes a €5,000 Regulatory Strategy Grant to accelerate your market entry.
• Selection: Evaluation is based on your  strategic evolution during the review sessions.

We welcome EIC awardees (Pathfinder, Transition, and Accelerator) and Seal of Excellence holders operating across the entire Technology Readiness Level spectrum (TRL 1–9). Our primary focus areas include:

• Biotechnology and Life Science Tools

• Diagnostics and Precision Medicine

• Digital Health and MedTech

• Pharmaceuticals

Deadline: Apply until 9th March 2026